CTRI/2015/06/005899招募中3 期
Ayurvedic formulation developed for the prevention and management of Metabolic syndrome and cardiovascular risk
Adesh University0 个研究点目标入组 1,000 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Triglycerides >150 mg%
- •2. Abdominal girth Male > 102 cm and Female > 85 cm
- •3. BP systolic > 130 mm Hg and Diastolic > 85 mm Hg
- •4. HDL < 40 mg% in Male and < 50 mg% in Female
- •5. Fasting Blood Sugar > 100 mg%
排除标准
- •1. FBS <100 mg%
- •2. TG <150 mg%
- •3. BP Systolic < 130 mmHg and Diastolic <85mmHg
研究者
相似试验
招募中
3 期
Treatment of Irritable Bowel Syndrome (IBS) by a plant based Ayurvedic formulatioCTRI/2015/05/005791Adesh University1,000
招募中
3 期
Ayurvedic intervention for prevention of acute pain crises in Sickle Cell AnaemiaCTRI/2023/04/052141Central Council for Research in Ayurvedic Sciences
尚未招募
2 期
Protect and prevent onset of COVID like infections in Health Care Workers and High risk person.CTRI/2020/05/025334Health Solutions
进行中（未招募）
3 期
Prevention and management of neurodegenerative disorders by an Ayurvedic formulatioCTRI/2014/12/005312Department of Science Technology
已完成
2 期
Tablet PINAK given as treatment to COVID positive patients.CTRI/2020/05/025326Shree Bharadi Ayurvedic106